MedTrace Logo

Application of EFT in Postmenopausal Women

NCT07065526 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2025-07-15

No results posted yet for this study

Summary

Objectives: This study was conducted to determine the effect of emotional liberation technique on sleep and quality of life in postmenopausal women.

Methods: The study was conducted as a randomized controlled trial with 58 women in a university hospital in Turkey. Of the women, 29 were in the intervention group and 29 were in the control group. Data were collected using the Personal Information Form, Subjective Experience Unit Scale (SUE), Pittsburg Sleep Quality Index (PSQI) and Menopause Specific Quality of Life Scale (MENQOL). EFT was applied to women in the intervention group four times at one-week intervals. The emotional liberation technique was applied to the women in the control group after the post-test was applied and the data were reported.

Conditions

  • Postmenopausal
  • Sleep
  • Quality of Life

Interventions

BEHAVIORAL

Emodin

Following the pre-test in the first encounter, the participants were administered the first EFT lasting 30-40 minutes by the first author, who is a certified EFT facilitator, followed by the CPS. Afterwards, a total of 4 sessions of EFT were administered at 1-week intervals. The CPS was applied before and after each EFT. After the last EFT session, SUE, PSQI and MENQOL post-tests were administered.

Sponsors & Collaborators

  • KTO Karatay University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-15
Primary Completion
2024-01-15
Completion
2024-09-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07065526 on ClinicalTrials.gov